BACKGROUND: Stroke is a potentially fatal complication of sickle cell disease in children between 2-16 years and transcranial Döppler has been recommended as a screening method in these cases. OBJECTIVE: The main goal of this study was to correlate transcranial Döppler results to complications related to stroke in sickle cell disease and baseline characteristics of the population. METHODS: This was an observational study of children and adolescents with ages between 2-16 years with sickle cell disease who were followed in three centers. RESULTS: From January 2008 to July 2009, 902 patients were enrolled in this study. The median age was 6.5 years (range: 1.8-15.8), 52.3% were male, 74.4% had hemoglobin SS; 221 (28.6%) had at least one complication associated with sickle cell disease. A total of 773 patients performed transcranial Döppler; in 91.2% this was a method of screening. Conditional or abnormal transcranial Döppler results were more common in patients with sickle cell disease complications versus those without complications (ODDS ratio = 3.18; 95% Confidence interval = 1.92-5.27). There was a significant difference in the frequency of conditional or abnormal transcranial Döppler results in patients with abnormal laboratory results compared to those without abnormalities (OR=4.03); 95% confidence interval = 2.30-7.06. CONCLUSIONS: Conditional or abnormal transcranial Döppler results were significantly more frequent in patients with complications of sickle cell disease confirming the increased risk of stroke in this subgroup of patients. This observation reinforces the recommendation of transcranial Döppler as a screening test for all patients with sickle cell disease with ages between 2 and 16 years.
BACKGROUND:Stroke is a potentially fatal complication of sickle cell disease in children between 2-16 years and transcranial Döppler has been recommended as a screening method in these cases. OBJECTIVE: The main goal of this study was to correlate transcranial Döppler results to complications related to stroke in sickle cell disease and baseline characteristics of the population. METHODS: This was an observational study of children and adolescents with ages between 2-16 years with sickle cell disease who were followed in three centers. RESULTS: From January 2008 to July 2009, 902 patients were enrolled in this study. The median age was 6.5 years (range: 1.8-15.8), 52.3% were male, 74.4% had hemoglobin SS; 221 (28.6%) had at least one complication associated with sickle cell disease. A total of 773 patients performed transcranial Döppler; in 91.2% this was a method of screening. Conditional or abnormal transcranial Döppler results were more common in patients with sickle cell disease complications versus those without complications (ODDS ratio = 3.18; 95% Confidence interval = 1.92-5.27). There was a significant difference in the frequency of conditional or abnormal transcranial Döppler results in patients with abnormal laboratory results compared to those without abnormalities (OR=4.03); 95% confidence interval = 2.30-7.06. CONCLUSIONS: Conditional or abnormal transcranial Döppler results were significantly more frequent in patients with complications of sickle cell disease confirming the increased risk of stroke in this subgroup of patients. This observation reinforces the recommendation of transcranial Döppler as a screening test for all patients with sickle cell disease with ages between 2 and 16 years.
Authors: Mounzer Y Kassab; Arshad Majid; Muhammad U Farooq; Hend Azhary; Linda A Hershey; Edward M Bednarczyk; Dion F Graybeal; Mark D Johnson Journal: J Am Board Fam Med Date: 2007 Jan-Feb Impact factor: 2.657
Authors: E Fadlon; S Vordermeier; T C Pearson; A R Mire-Sluis; D C Dumonde; J Phillips; K Fishlock; K A Brown Journal: Blood Date: 1998-01-01 Impact factor: 22.113
Authors: O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug Journal: N Engl J Med Date: 1994-06-09 Impact factor: 91.245
Authors: R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla Journal: N Engl J Med Date: 1998-07-02 Impact factor: 91.245
Authors: Clarisse Lopes de Castro Lobo; Rodolfo Delfini Cançado; Ana Claudia Celestino Bezerra Leite; Ana Claudia Mendonça Dos Anjos; Ana Cristina Silva Pinto; Andre Palma da Cunha Matta; Célia Maria Silva; Gisele Sampaio Silva; João Ricardo Friedrisch; Josefina Aparecida Pellegrini Braga; Marcos Christiano Lange; Maria Stella Figueiredo; Marília Álvares Rugani; Orlando Veloso; Patrícia Gomes Moura; Paulo Ivo Cortez; Robert Adams; Sandra Fátima Menosi Gualandro; Shirley Lopes de Castilho; Ursula Thomé; Viviane Flumignan Zetola Journal: Rev Bras Hematol Hemoter Date: 2011
Authors: Richard Idro; Amelia K Boehme; Michael Kawooya; Samson K Lubowa; Deogratias Munube; Paul Bangirana; Robert Opoka; Ezekiel Mupere; Angela Lignelli; Philip Kasirye; Nancy S Green; Frank J Minja Journal: J Stroke Cerebrovasc Dis Date: 2022-02-11 Impact factor: 2.136
Authors: Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk Journal: Paediatr Respir Rev Date: 2013-11-15 Impact factor: 2.726